Literature DB >> 21562117

Human papillomavirus infection in nasal polyps in a Chinese population.

Fei Pei1, Xiao-Ping Chen2, Yi Zhang2, Yan Wang1, Qun Chen2, Xue-Jun Tan3, Jing-Fei Zhang2, Xiao-Cheng Xue1, Jian Wu4, Zhi-Rong Qing5.   

Abstract

In order to determine the prevalence and genotype distribution of human papillomavirus (HPV) infection in patients with nasal polyps, a total of 204 patients with nasal polyps and 36 healthy controls were recruited for this study. Genomic DNA was extracted from paraffin-embedded tissue sections. HPV DNA genotyping was achieved by a flow-through hybridization and gene-chip method. HPV-positive infection was identified in 82 of 204 (40.2 %) patients, while HPV DNA was not found in healthy controls (P<0.05). Genotyping analysis showed that low-risk HPV genotype 11 was the most prevalent type of HPV in nasal polyps (45.28 %). Both single and multiple HPV genotype infections were found in these HPV-positive cases, although most (74.39 %) were infected with a single genotype. In addition, there was no correlation between HPV infection or HPV subtypes and the clinicopathological characteristics of patients, such as age, gender, number of surgery and disease course. The data from our study clearly demonstrated that HPV infection was associated with nasal polyps. Both high-risk HPV and low-risk HPV (LR-HPV) genotypes were identified in nasal polyp tissues, and LR-HPV-11 was the most prevalent type. Future research will explore the association of HPV infection with the development and progression of nasal polyps.

Entities:  

Mesh:

Year:  2011        PMID: 21562117     DOI: 10.1099/vir.0.031955-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Anal HPV/HIV co-infection among Men Who Have Sex with Men: a cross-sectional survey from three cities in China.

Authors:  Xiangwei Li; Mufei Li; Yu Yang; Xiang Zhong; Boxuan Feng; Henan Xin; Zhen Li; Qi Jin; Lei Gao
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

2.  Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer.

Authors:  Yi Hao; Ming Ye; Xiaona Chen; Hongli Zhao; Ayshamgul Hasim; Xia Guo
Journal:  Cancer Cell Int       Date:  2021-02-18       Impact factor: 5.722

3.  Association between oncogenic human papillomavirus type 16 and Killian polyp.

Authors:  Lucia Oton-Gonzalez; John Charles Rotondo; Luca Cerritelli; Nicola Malagutti; Carmen Lanzillotti; Ilaria Bononi; Andrea Ciorba; Chiara Bianchini; Chiara Mazziotta; Monica De Mattei; Stefano Pelucchi; Mauro Tognon; Fernanda Martini
Journal:  Infect Agent Cancer       Date:  2021-01-07       Impact factor: 2.965

4.  Sensitive HPV genotyping based on the flow-through hybridization and gene chip.

Authors:  Pingping Tao; Weiping Zheng; Yungen Wang; Mei-Lu Bian
Journal:  J Biomed Biotechnol       Date:  2012-10-11

5.  Infection and HLA-G molecules in nasal polyposis.

Authors:  Roberta Rizzo; Nicola Malagutti; Daria Bortolotti; Valentina Gentili; Antonella Rotola; Enrico Fainardi; Teresa Pezzolo; Claudia Aimoni; Stefano Pelucchi; Dario Di Luca; Antonio Pastore
Journal:  J Immunol Res       Date:  2014-03-06       Impact factor: 4.818

6.  Human Papillomavirus (HPV) Prevalence in Nasal and Antrochoanal Polyps and Association with Clinical Data.

Authors:  Mareike Knör; Konstantin Tziridis; Abbas Agaimy; Johannes Zenk; Olaf Wendler
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

7.  Distribution characteristics of different human papillomavirus genotypes in women in Wuhan, China.

Authors:  Feiyan Xiang; Qing Guan; Xinwen Liu; Han Xiao; Qian Xia; Xiuzhen Liu; Hong Sun; Xiaojie Song; Yuanyuan Zhong; Chun-Hui Yuan; Yun Xiang
Journal:  J Clin Lab Anal       Date:  2018-06-03       Impact factor: 2.352

8.  Herpes viruses and human papilloma virus in nasal polyposis and controls.

Authors:  Dimitrios Ioannidis; Vasileios A Lachanas; Zoe Florou; John G Bizakis; Efthymia Petinaki; Charalampos E Skoulakis
Journal:  Braz J Otorhinolaryngol       Date:  2015-09-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.